Computational prediction of genotoxicity: room for improvement.
暂无分享,去创建一个
[1] Ann M Richard,et al. Distributed structure-searchable toxicity (DSSTox) public database network: a proposal. , 2002, Mutation research.
[2] H. Rosenkranz,et al. SAR modeling of genotoxic phenomena: the effect of supplementation with physiological chemicals. , 2001, Mutation research.
[3] Alessandro Giuliani,et al. Quantitative Structure-Activity Relationship (QSAR) - Studies of Mutagens and Carcinogens , 1996 .
[4] R Benigni,et al. QSARS of mutagens and carcinogens: two case studies illustrating problems in the construction of models for noncongeneric chemicals. , 1996, Mutation research.
[5] Neal F. Cariello,et al. Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity. Deductive Estimate of Risk from Existing Knowledge. Toxicity Prediction by Komputer Assisted Technology. , 2002, Mutagenesis.
[6] L. Hall,et al. Three new consensus QSAR models for the prediction of Ames genotoxicity. , 2004, Mutagenesis.
[7] H S Rosenkranz,et al. Sar modeling of unbalanced data sets , 2001, SAR and QSAR in environmental research.
[8] D J Livingstone,et al. Modelling mutagenicity using properties calculated by computational chemistry , 2002, SAR and QSAR in environmental research.
[9] Peter C Jurs,et al. Predicting the genotoxicity of thiophene derivatives from molecular structure. , 2003, Chemical research in toxicology.
[10] Nigel Greene,et al. Computer systems for the prediction of toxicity: an update. , 2002, Advanced drug delivery reviews.
[11] R. Tennant,et al. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 39 chemicals tested for carcinogenicity by the U.S. National Toxicology Program. , 1991, Mutation research.
[12] E Zeiger,et al. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program. , 1989, Mutation research.
[13] R. Snyder,et al. The influence of N-dialkyl and other cationic substituents on DNA intercalation and genotoxicity. , 2005, Mutation research.
[14] L. Ferguson. Inhibitors of topoisomerase II enzymes: a unique group of environmental mutagens and carcinogens. , 1998, Mutation research.
[15] E. D. Bransome,et al. The ligand insertion hypothesis in the genomic action of steroid hormones 1 1 Proceedings of the 13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology “Recent Advances in Steroid Biochemistry & Molecular Biology” Monaco 25–28 May 1997. , 1998, The Journal of Steroid Biochemistry and Molecular Biology.
[16] Herbert S Rosenkranz,et al. SAR modeling of genotoxic phenomena: the consequence on predictive performance of deviation from a unity ratio of genotoxicants/non-genotoxicants. , 2004, Mutation research.
[17] Ronald D Snyder,et al. Evaluation of DNA intercalation potential of pharmaceuticals and other chemicals by cell‐based and three‐dimensional computational approaches , 2004, Environmental and molecular mutagenesis.
[18] J. Copland,et al. Design of novel antiestrogens , 1994, The Journal of Steroid Biochemistry and Molecular Biology.
[19] Peter C Jurs,et al. Predicting the genotoxicity of polycyclic aromatic compounds from molecular structure with different classifiers. , 2003, Chemical research in toxicology.
[20] P. Jurs,et al. Development of binary classification of structural chromosome aberrations for a diverse set of organic compounds from molecular structure. , 2003, Chemical research in toxicology.
[21] V. Mahesh,et al. Multidimensional screening and design of pharmaceuticals by using endocrine pharmacophores , 1999, Steroids.
[22] Stephen K. Durham,et al. Predicting the Genotoxicity of Secondary and Aromatic Amines Using Data Subsetting to Generate a Model Ensemble. , 2003 .
[23] J W Green,et al. A review of the genotoxicity of marketed pharmaceuticals. , 2001, Mutation research.
[24] J. Votano,et al. Recent uses of topological indices in the development of in silico ADMET models. , 2005, Current opinion in drug discovery & development.
[25] R. Tennant,et al. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.
[26] E. Dybing,et al. Comparison of carcinogenic and in vivo genotoxic potency estimates. , 2005, Basic & clinical pharmacology & toxicology.
[27] Alan G. E. Wilson,et al. A multiple in silico program approach for the prediction of mutagenicity from chemical structure. , 2003, Mutation research.
[28] R. Snyder,et al. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules , 2004, Environmental and molecular mutagenesis.
[29] Subhash C. Basak,et al. Prediction of Mutagenicity of Aromatic and Heteroaromatic Amines from Structure: A Hierarchical QSAR Approach , 2001, J. Chem. Inf. Comput. Sci..